Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Blockchain in Genomics Market by Type (Utility Tokens, Blockchain Platforms), By Application (Pharmaceutical and Biotechnology Companies, Hospitals and Healthcare Providers, Research Institutes, Data Owners, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Blockchain in Genomics Market by Type (Utility Tokens, Blockchain Platforms), By Application (Pharmaceutical and Biotechnology Companies, Hospitals and Healthcare Providers, Research Institutes, Data Owners, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 231661 4200 Service & Software 377 120 Pages 4.5 (33)
                                          

Market Overview:


The global blockchain in genomics market is expected to grow at a CAGR of over 38% during the forecast period from 2018 to 2030. The growth of the market can be attributed to various factors such as the increasing demand for precision medicine, rising number of genomic data-sets, and growing focus on research and development activities in the field of genomics. The blockchain platforms segment is expected to hold a dominant position in the global blockchain in genomics market during the forecast period. This can be attributed to various benefits offered by these platforms such as secure data sharing, tamper-proof records, and faster transactions. The pharmaceutical and biotechnology companies segment is projected to witness highest growth rate during the forecast period owing to increasing adoption of precision medicine across this sector. Geographically, North America is estimated to account for a major share of the global blockchain in genomics market in 2018.


Global Blockchain in Genomics Industry Outlook


Product Definition:


Blockchain is a distributed database technology that enables secure, transparent and tamper-proof transactions of digital data. In the context of genomics, blockchain could be used to store and track genomic data as it moves through the sequencing process and is made available for research purposes. The use of blockchain would ensure that data is properly authenticated and its integrity maintained, which could help to reduce errors and fraud in genomic research.


Utility Tokens:


Utility tokens are digital assets designed to provide access to a platform or network. They can be used for accessing premium services offered by the company. The value of utility tokens is derived from the use of it in the service, which makes it more like a conventional currency. Utility tokens are usually used as a medium of exchange on exchanges and online marketplaces where different cryptocurrencies are bought and sold.


Blockchain Platforms:


A blockchain platform is a software system that enables the recording and transference of data on a decentralized network. It comprises an engine to execute smart contracts, which are basically codes that facilitate transactions between two parties. The blockchain technology facilitates secure data transfer by creating an encrypted chain of blocks without the need for a central authority or middleman.


The major application areas where this technology is being used currently include financial services, supply chain management, healthcare industry,.


Application Insights:


The pharmaceutical and biotechnology companies accounted for the largest revenue share in 2017. The segment is expected to continue its dominance over the forecast period owing to increasing R&D activities pertaining to genomic information and its applications. Increasing adoption of blockchains across this industry has enabled secure data sharing among participants, which includes researchers, clinical trialists, data managers and others.


The hospitals and healthcare providers are also anticipated to witness significant growth over the forecast period as they can utilize this technology for securely registering medical records & procedures as well as avoiding frauds during payments. Furthermore, blockchain-based solutions can help reduce costs associated with intermediaries by reducing paperwork & errors caused due to human error or process inefficiency resulting in substantial cost savings for organizations that use these technologies consistently. These advantages are expected drive their demand across various segments of hospitals & healthcare providers globally over the coming years (see figure below).


Regional Analysis:


The North American regional market dominated the global market in genomics and is expected to grow at a significant rate over the forecast period. The growth of this region can be attributed to an increase in R&D investments by major players, growing adoption of new technologies, and increasing focus on precision medicine research. Moreover, rising awareness regarding advanced healthcare solutions among patients is anticipated to drive demand for genomic-based services across this region.


Asia Pacific is projected to witness lucrative growth during the forecast period owing to factors such as favorable government policies that support innovation through technology transfer coupled with increasing number of initiatives taken up by private companies for developing novel applications based on block chain technology. In addition, booming medical tourism industry due to availability of advanced treatments at affordable costs will boost demand for genomic testing across APAC countries such as China and India thereby driving regional market growth over the forecast period.


Growth Factors:


  • Increasing demand for personalized medicine
  • Growing application of blockchain in healthcare sector
  • Rising popularity of genomic sequencing services
  • Proliferation of digital health records and data sharing platforms
  • Development of innovative blockchain-based genomic data management solutions

Scope Of The Report

Report Attributes

Report Details

Report Title

Blockchain in Genomics Market Research Report

By Type

Utility Tokens, Blockchain Platforms

By Application

Pharmaceutical and Biotechnology Companies, Hospitals and Healthcare Providers, Research Institutes, Data Owners, Others

By Companies

Digital DNAtix Ltd, EncrypGen, Genobank.io Inc, Genomes.io, Longenesis, LunaDNA, Nebula Genomics, Shivom Ventures Limited, WuXi Nextcode(Genomics Medicine Ireland), Zenome.io Ltd, Block23

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

120

Number of Tables & Figures

84

Customization Available

Yes, the report can be customized as per your need.


Global Blockchain in Genomics Market Report Segments:

The global Blockchain in Genomics market is segmented on the basis of:

Types

Utility Tokens, Blockchain Platforms

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical and Biotechnology Companies, Hospitals and Healthcare Providers, Research Institutes, Data Owners, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Digital DNAtix Ltd
  2. EncrypGen
  3. Genobank.io Inc
  4. Genomes.io
  5. Longenesis
  6. LunaDNA
  7. Nebula Genomics
  8. Shivom Ventures Limited
  9. WuXi Nextcode(Genomics Medicine Ireland)
  10. Zenome.io Ltd
  11. Block23

Global Blockchain in Genomics Market Overview


Highlights of The Blockchain in Genomics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Utility Tokens
    2. Blockchain Platforms
  1. By Application:

    1. Pharmaceutical and Biotechnology Companies
    2. Hospitals and Healthcare Providers
    3. Research Institutes
    4. Data Owners
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Blockchain in Genomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Blockchain in Genomics Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Blockchain is a distributed database that allows for secure, transparent and tamper-proof transactions. It was first developed as a way to track the ownership of digital assets such as bitcoin. However, it has since been used in many other industries, including genomics.nnOne use case for blockchain in genomics is tracking the ownership of genetic data. This data can be used to identify individuals and their families, and it can also be sold or licensed to third parties. Blockchain technology makes this process more secure by allowing users to track who owns what data and how it is being used.

Some of the major companies in the blockchain in genomics market are Digital DNAtix Ltd, EncrypGen, Genobank.io Inc, Genomes.io, Longenesis, LunaDNA, Nebula Genomics, Shivom Ventures Limited, WuXi Nextcode(Genomics Medicine Ireland), Zenome.io Ltd, Block23.

The blockchain in genomics market is expected to register a CAGR of 38%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blockchain in Genomics Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Blockchain in Genomics Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Blockchain in Genomics Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Blockchain in Genomics Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Blockchain in Genomics Market Size & Forecast, 2018-2028       4.5.1 Blockchain in Genomics Market Size and Y-o-Y Growth       4.5.2 Blockchain in Genomics Market Absolute $ Opportunity

Chapter 5 Global Blockchain in Genomics Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Blockchain in Genomics Market Size Forecast by Type
      5.2.1 Utility Tokens
      5.2.2 Blockchain Platforms
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Blockchain in Genomics Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Blockchain in Genomics Market Size Forecast by Applications
      6.2.1 Pharmaceutical and Biotechnology Companies
      6.2.2 Hospitals and Healthcare Providers
      6.2.3 Research Institutes
      6.2.4 Data Owners
      6.2.5 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Blockchain in Genomics Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Blockchain in Genomics Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Blockchain in Genomics Analysis and Forecast
   9.1 Introduction
   9.2 North America Blockchain in Genomics Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Blockchain in Genomics Market Size Forecast by Type
      9.6.1 Utility Tokens
      9.6.2 Blockchain Platforms
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Blockchain in Genomics Market Size Forecast by Applications
      9.10.1 Pharmaceutical and Biotechnology Companies
      9.10.2 Hospitals and Healthcare Providers
      9.10.3 Research Institutes
      9.10.4 Data Owners
      9.10.5 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Blockchain in Genomics Analysis and Forecast
   10.1 Introduction
   10.2 Europe Blockchain in Genomics Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Blockchain in Genomics Market Size Forecast by Type
      10.6.1 Utility Tokens
      10.6.2 Blockchain Platforms
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Blockchain in Genomics Market Size Forecast by Applications
      10.10.1 Pharmaceutical and Biotechnology Companies
      10.10.2 Hospitals and Healthcare Providers
      10.10.3 Research Institutes
      10.10.4 Data Owners
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Blockchain in Genomics Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Blockchain in Genomics Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Blockchain in Genomics Market Size Forecast by Type
      11.6.1 Utility Tokens
      11.6.2 Blockchain Platforms
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Blockchain in Genomics Market Size Forecast by Applications
      11.10.1 Pharmaceutical and Biotechnology Companies
      11.10.2 Hospitals and Healthcare Providers
      11.10.3 Research Institutes
      11.10.4 Data Owners
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Blockchain in Genomics Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Blockchain in Genomics Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Blockchain in Genomics Market Size Forecast by Type
      12.6.1 Utility Tokens
      12.6.2 Blockchain Platforms
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Blockchain in Genomics Market Size Forecast by Applications
      12.10.1 Pharmaceutical and Biotechnology Companies
      12.10.2 Hospitals and Healthcare Providers
      12.10.3 Research Institutes
      12.10.4 Data Owners
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Blockchain in Genomics Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Blockchain in Genomics Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Blockchain in Genomics Market Size Forecast by Type
      13.6.1 Utility Tokens
      13.6.2 Blockchain Platforms
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Blockchain in Genomics Market Size Forecast by Applications
      13.10.1 Pharmaceutical and Biotechnology Companies
      13.10.2 Hospitals and Healthcare Providers
      13.10.3 Research Institutes
      13.10.4 Data Owners
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Blockchain in Genomics Market: Competitive Dashboard
   14.2 Global Blockchain in Genomics Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Digital DNAtix Ltd
      14.3.2 EncrypGen
      14.3.3 Genobank.io Inc
      14.3.4 Genomes.io
      14.3.5 Longenesis
      14.3.6 LunaDNA
      14.3.7 Nebula Genomics
      14.3.8 Shivom Ventures Limited
      14.3.9 WuXi Nextcode(Genomics Medicine Ireland)
      14.3.10 Zenome.io Ltd
      14.3.11 Block23

Our Trusted Clients

Contact Us